Reported figures and Equlion model projections for the next 5 years.
ROE
-11.1 pt
Company
Sector average
ROA
+339.5 pt
Company
Gross Margin
+0 pt
Company
Sector average
Net Margin
+249.8 pt
Company
Total Assets
+62.9%
Company
Net Income
+16.5%
Company
Detailed data
USD
Amounts in USD; stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Regen BioPharma Inc? It covers the balance sheet, income statement, cash flow and Equlion model projections.